The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verani, A.
Right arrow Articles by Vercelli, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verani, A.
Right arrow Articles by Vercelli, D.
The Journal of Immunology, 2002, 168: 6388-6395.
Copyright © 2002 by The American Association of Immunologists

Inhibition of CXCR4-Tropic HIV-1 Infection by Lipopolysaccharide: Evidence of Different Mechanisms in Macrophages and T Lymphocytes1

Alessia Verani2,*, Francesca Sironi*, Antonio G. Siccardi{dagger}, Paolo Lusso* and Donata Vercelli{ddagger}

* Human Virology Unit, DIBIT, San Raffaele Scientific Institute, and {dagger} Department of Biology and Genetics, University of Milan, Milan, Italy; and {ddagger} Respiratory Sciences Center, College of Medicine, University of Arizona, Tucson, AZ 85724

Bacterial LPS protects primary human macrophages from infection by CCR5-tropic HIV-1 isolates through the release of the CC chemokines RANTES and macrophage inflammatory protein-1{alpha} and -1{beta}. Here, we show that LPS also suppresses infection of macrophages by CXCR4-tropic HIV-1 isolates. A marked down-regulation of both CD4 and CXCR4 expression was associated with this effect. Furthermore, a soluble factor(s) released by macrophages upon LPS treatment inhibited infection with CXCR4-tropic HIV-1 isolate viruses in both macrophages and T lymphocytes. Infection of both cell types appeared to be blocked at the level of viral entry and was independent of stromal cell-derived factor-1, the only known natural ligand of CXCR4. Moreover, the suppressive effect of LPS was unrelated to the release of IFN-{alpha} and -{beta}, macrophage-derived chemokine, leukemia inhibitory factor, or TNF-{alpha}. These results suggest the existence of potent HIV-1 inhibitory factor(s), uncharacterized to date, released by activated cells of the mononuclear phagocytic system.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
N. F. Pinheiro Jr., M. D. R. Hermida, M. P. Macedo, J. Mengel, A. Bafica, and W. L. C. dos-Santos
Leishmania Infection Impairs {beta}1-Integrin Function and Chemokine Receptor Expression in Mononuclear Phagocytes
Infect. Immun., July 1, 2006; 74(7): 3912 - 3921.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. Sun, C. M. Finnegan, T. Kish-Catalone, R. Blumenthal, P. Garzino-Demo, G. M. La Terra Maggiore, S. Berrone, C. Kleinman, Z. Wu, S. Abdelwahab, et al.
Human {beta}-Defensins Suppress Human Immunodeficiency Virus Infection: Potential Role in Mucosal Protection
J. Virol., November 15, 2005; 79(22): 14318 - 14329.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Zhang, G. Li, A. Bafica, M. Pantelic, P. Zhang, H. Broxmeyer, Y. Liu, L. Wetzler, J. J. He, and T. Chen
Neisseria gonorrhoeae Enhances Infection of Dendritic Cells by HIV Type 1
J. Immunol., June 15, 2005; 174(12): 7995 - 8002.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Bafica, C. A. Scanga, O. Equils, and A. Sher
The induction of Toll-like receptor tolerance enhances rather than suppresses HIV-1 gene expression in transgenic mice
J. Leukoc. Biol., March 1, 2004; 75(3): 460 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. L. Humphreys, C. T. Schnizlein-Bick, B. P. Katz, L. A. Baldridge, A. F. Hood, R. A. Hromas, and S. M. Spinola
Evolution of the Cutaneous Immune Response to Experimental Haemophilus ducreyi Infection and Its Relevance to HIV-1 Acquisition
J. Immunol., December 1, 2002; 169(11): 6316 - 6323.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.